According to a recent LinkedIn post from Certify, the company is drawing attention to revenue leakage in dermatology practices stemming from workflow inefficiencies rather than weak patient demand. The post highlights issues such as performing insurance verification after scheduling, patients arriving without required information, and mismatches between scheduled and actual visit duration.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests these process gaps can delay payments, reduce reimbursement capture, and limit daily patient throughput, effectively constraining revenue before a visit begins. For investors, this focus indicates Certify may be positioning its offerings around end-to-end workflow visibility and revenue optimization, targeting a clear pain point for growth-minded dermatology practices.
If this positioning resonates with providers, Certify could deepen its value proposition in the dermatology vertical and potentially increase adoption among practices seeking scalable, efficiency-driven growth. Emphasis on measurable revenue recovery and operational consistency may also support pricing power and customer retention in a competitive health IT and practice-management market.

